✦ LIBER ✦

Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC)

✍ Scribed by Ander Urruticoechea; Monica Arnedos; Geraldine Walsh; Mitch Dowsett; Ian E. Smith

Publisher: Springer US
Year: 2007
Tongue: English
Weight: 188 KB
Volume: 110
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-007-9745-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bone mineral density loss during adjuvan

Bone mineral density loss during adjuvant chemotherapy in pre-menopausal women with early breast cancer: is it dependent on oestrogen deficiency?

✍ David A. Cameron; Sharon Douglas; Janet E. Brown; Richard A. Anderson 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 252 KB

Adjuvant goserelin and ovarian preservat

Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial

✍ A. Sverrisdottir; M. Nystedt; H. Johansson; T. Fornander 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 256 KB

Gonadotropin-releasing hormone analogues

Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma

✍ Francesco Recchia; Gaetano Saggio; Giovanna Amiconi; Anna Di Blasio; Alisia Cest 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

## Abstract ## BACKGROUND The objective of the current study was a retrospective evaluation of 100 consecutive premenopausal women with high‐risk, early breast carcinoma who received a gonadotropin‐releasing hormone (Gn‐RH) analogue as ovarian protection during adjuvant chemotherapy. ## METHODS

Adjuvant!©Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer

✍ Robert J. Paridaens; Shari Gelber; Bernard F. Cole; Richard D. Gelber; Beat Thür 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 238 KB